Logo

BGI-Shenzhen Extends Complete Genomics Offer

Jan 28, 2013 | staff reporter

NEW YORK (GenomeWeb News) – BGI-Shenzhen has extended its cash tender offer for Complete Genomics again, BGI announced late Friday.

The deal is now set to expire midnight EST, Feb. 1. It had been previously extended until midnight EST, Jan. 25.

The depositary for the offer has indicated that about 30,949,757 shares, or 87 percent, of Complete's common stock, have been validly tendered and not withdrawn. The $118 million deal has met various regulatory approvals, but a week ago BGI said that China's Ministry of Commerce and the State Administration of Foreign Exchange had not yet approved the acquisition. It did not update the status of those reviews on Friday.

Filed under

Clinical Sequencing
Sequencing
Business News
tender offer
mergers & acquisitions
MGI Tech
BGI
Breaking News
The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.